Methylphenidate, fluoxetin, risperidone
( DrugBank: Methylphenidate, Risperidone / KEGG DRUG: Methylphenidate hydrochloride, Methylphenidate, Risperidone )
2 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 179 | Williams syndrome | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 206 | Fragile X syndrome | 1 |
179. Williams syndrome
Clinical trials : 12 / Drugs : 21 - (DrugBank : 8) / Drug target genes : 9 - Drug target pathways : 35
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
206. Fragile X syndrome
Clinical trials : 124 / Drugs : 103 - (DrugBank : 35) / Drug target genes : 58 - Drug target pathways : 84
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|